Cencora Secures $1.5 Billion Term Loan and Expands Revolving Credit Facility to $5.5 Billion

Cencora Inc. has amended its existing revolving credit facility, increasing the total commitments under the agreement by $1.0 billion to $5.5 billion. The amendment, entered into on January 12, 2026, involves JPMorgan Chase Bank, N.A. as administrative agent and includes the company's borrowing subsidiaries and various lenders. Additionally, Cencora entered into a new senior unsecured term loan facility totaling $1.5 billion in connection with its proposed acquisition of the majority of outstanding equity interests in OneOncology. The term loan facility is split into two tranches: a $500 million tranche maturing in two years and a $1.0 billion tranche maturing in three years from the draw date. The company also established a 364-day term credit facility with Citibank, N.A. as administrative agent. Proceeds from the term loans will be used to finance the acquisition, repay existing debt of OneOncology, and cover related fees and expenses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cencora Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-004524), on January 16, 2026, and is solely responsible for the information contained therein.